Eastman Chemical Company's (NYSE:EMN) Q2 2025 earnings and revenues are reported to have missed their target, with a significant decrease in the year-over-year figures. This has led to a 19% plunge in the EMN stock value, making it the S&P 500's biggest loser. The company reportedly anticipates a challenging market scenario, nevertheless, signaling $75M–$100M in new
cost cuts and projecting demand stabilization in 2026 amid tariff volatility. Eastman Chemical's stock comes across as potentially undervalued by 40% and is stated to be among the oversold global stocks that should be bought according to hedge funds. Even with strategic moves amid challenges, the firm faces
macroeconomic headwinds. Interestingly, the company's stock performance has been said to be underperforming the Material Sector. Furthermore, it is reported that Eastman's board has appointed a
new director and the CFO from AGCO was added to its management team. It could be noted that the company's
specialty chemicals sector is indicated to show possible long-term growth despite tariff-related uncertainty.
Eastman Chemical Company EMN News Analytics from Tue, 15 Oct 2024 07:00:00 GMT to Sat, 02 Aug 2025 15:12:06 GMT -
Rating -8
- Innovation -2
- Information 7
- Rumor -6
